EDITOR, The Tribune.
When I read the article written by Dr. Pinto under the headline “You are not a horse - FDA warns against the use of ivermectin to treat COVID-19”, I was surprised to see how little of what he said was evidenced by any science.
The FDA consumer article that he quotes from states that “The FDA has not reviewed data to support use of ivermectin in COVID-19 patients to treat or prevent COVID-19!” So how can the FDA make its bold claims?
The FDA even states “Using the drug ivermectin to treat COVID-19 can be dangerous and even lethal”. This is surprising indeed, as Ivermectin is a drug that has been around for more than 30 years, one of the most distributed drugs on Earth, with more than 2.5 billion doses given out to humans. It is so safe that it is listed as one of WHO’s essential medicines! The Nobel-prize winning scientist, who won his prize for developing Ivermectin, Satoshi Omura, reported that the rate of serious adverse events for ivermectin is one per million doses.
Dr Pinto also says that “Ivermectin is not even an antiviral application.” I have found three studies that refute his statement. The June 2020 issue of the journal Antiviral Research “The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro” indicated a single treatment of ivermectin was able to cause a 5,000-fold reduction of SARS-CoV-2 in a cell culture within 48 hours.
A September 2020 article in the journal Cells, “Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?” reported that “cell culture experiments show (ivermectin exhibits) robust antiviral action towards HIV-1, dengue virus (DENV), Zika virus, West Nile virus, Venezuelan equine encephalitis virus, Chikungunya virus, Pseudorabies virus, adenovirus, and SARS-COV-2 (COVID-19.)”
A research article published by the Lancet on 17 June, 2001 determined the “Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial”.
Furthermore, there are over 70 studies showing its effectiveness as a prophylaxis and treatment. Not one of these studies states that ivermectin “can be dangerous or even lethal.” In fact, Theresa Lawrie’s meta study on Ivermectin’s dated 21 June, 2021 concluded “Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”
There are at least five protocols using Ivermectin as a combination therapeutic currently being used by physicians with positive results (with up to 85% reduction in hospitalizations): 1/ Thomas Borody triple therapy, 2/ I-MASK+ Prevention & Early Outpatient Treatment Protocol for COVID-19, 3/ Dr. Peter McCollough COVID Treatment, 4/ The Zelenko protocol, and 5/ Ivermectin + Iota-Carrageenan protocol.
Instead of demonising Ivermectin, why don’t we take some time and review the mounting evidence. If the protocols described above are effective, should we not be trying them here? Could they possibly save lives? I challenge our physicians to think outside the box.
Even the Wall Street Journal recently questioned the FDA’s science when it published an oped piece on 28 July, 2021 entitled “why is the FDA attacking a Safe, Effective Drug?” Dr Pinto would be well advised to read it.
September 2, 2021.